United Kingdom · Who invested in PrEP Biopharm?
PrEP Biopharm's investors include Johnson & Johnson Innovation and hVIVO plc.
United Kingdom · Series A startup
Who invested in PrEP Biopharm
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow PrEP Biopharm and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$32Mraised across 1 round since 2015, from 1 source
- Latest round
- Series A, $32MNov 2015
- Investors
- 2
The rounds
- Nov 2015Series A$32M
- Johnson & Johnson Innovation
- hVIVO plc
From a historical funding recordSEC filing: $32M sold, first sale Nov 2015
Quick answers about PrEP Biopharm
How much has PrEP Biopharm raised?
PrEP Biopharm has raised $32M across 1 round since 2015.
When did PrEP Biopharm last raise?
PrEP Biopharm's most recent round was a Series A of $32M in Nov 2015.
What was PrEP Biopharm's biggest round?
Its most recent round, $32M in Nov 2015, is also its largest on record.
Who backed PrEP Biopharm first?
PrEP Biopharm's first round on record, in Nov 2015, was backed by Johnson & Johnson Innovation and hVIVO plc.
What stage is PrEP Biopharm at?
PrEP Biopharm's latest named round is a Series A, in Nov 2015.
Where is PrEP Biopharm based?
PrEP Biopharm is based in the United Kingdom.
Companies like PrEP Biopharm
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.